Endometriosis affects 10% of women of reproductive age, yet diagnosis is often delayed by 8-12 years due to reliance on invasive laparoscopy or rare ultrasound experts. Scanvio is developing AI-powered software that transforms standard ultrasound devices into expert diagnostic tools, reducing time to diagnosis to 1-3 years. The technology provides real-time guidance and anatomical labeling based on clinical standards, enabling broader access to accurate, non-invasive diagnostics. The founding team combines leading expertise in AI and ultrasound, clinical excellence, and a serial MedTech entrepreneur.
Venture Leaders Medtech 2025: Captain's blog by Stefan Tuchschmid, Co-Founder of Scanvio Medical (venturelab.swiss)
Venture Leaders Medtech Roadshow 2025: Swiss Medtech startups shine in Boston (venturelab.swiss)
Scanvio Medical: The Venture Leader Medtech harnessing AI for faster non-invasive endometriosis detection (venturelab.swiss)
Venture Leaders Medtech 2025 kick-off their Boston roadshow (venturelab.swiss)
Scanvio secures $3.4M to enable earlier diagnosis of endometriosis (startupticker.ch)
Scanvio raises USD 3.4M to advance AI-guided ultrasound for endometriosis diagnosis (venturelab.swiss)
Ten Medtech startups to explore US expansion opportunities (startupticker.ch)
Venture Leaders Medtech 2025: Ten Swiss startups selected for US expansion (venturelab.swiss)
Driving the ecosystem forward (startupticker.ch)
CHF 150,000 from Venture Kick to democratize expert ultrasound (startupticker.ch)
Scanvio gets CHF 150,000 from Venture Kick to democratize expert ultrasound (venturekick.ch)
InnoBooster startups address health and environmental issues (startupticker.ch)
New portfolio companies for S2S Ventures (startupticker.ch)
First Patient Scanning